Wednesday, Dec 27, 2023 · SEC filings
What the smart money revealed on Dec 27
259 insider filings came in. We hid 56 planned (10b5-1) sellers and 119 people whose filings were routine, like grants and tax withholding.
3 insiders at Moleculin Biotech (MBRX) bought $160K of stock
Roles: CEO, CFO, Director. Several insiders buying in the same few days is rare.
Unifi (UFI) Director Kenneth Langone bought $2.88M
500,000 shares on the open market. Not a grant or an option exercise. Their past buys: 1 of 3 checked quarters beat the typical stock 6 months later.
Sanfilippo John B & Son (JBSS) COO Jasper Sanfilippo Jr. bought $318K
3,027 shares on the open market. Not a grant or an option exercise.
CSB Bancorp (CSBB) President and CEO Eddie Steiner bought $76K
2,000 shares on the open market. Not a grant or an option exercise.
American Picture House (APHP) President Alfred Luessenhop Jr. bought $50K
200,000 shares on the open market. Not a grant or an option exercise.
Cintas (CTAS) VP and CFO J. Michael Hansen sold $5.83M
Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 37,732 shares directly.
JFrog (FROG) CEO Ben Shlomi sold $4.56M
Not marked as a planned 10b5-1 sale. Sold 3% of the shares they held directly. Still holds 5.05M shares.
Toro (TTC) Director Janet Cooper sold $258K
Not marked as a planned 10b5-1 sale. Sold every share held directly.
Show 23 more real buys
Show 34 more real sales
13F season
Holdings as of Sep 30, 2023 were due Nov 14
40 funds have filed. 40 filed for the quarter before.
Biggest real insider buys, Dec 21–27
Open-market buys by officers and directors, filed in the 7 days up to Dec 27.
Free weekly email
Each week's biggest real insider buys, cluster buys and fund moves, every one dated. One email a week. Unsubscribe in one click.